ARTICLE | Company News
Embera, NIH neurology news
August 15, 2016 7:00 AM UTC
Embera received an $11.1 million, three-year grant from NIH’s National Institute on Drug Abuse (NIDA) to develop metyrapone/oxazepam ( EMB-001) to treat cocaine use disorder. Embera is evaluating the ...